PET DIABETES CARE DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In November 2023, Boehringer Ingelheim received European approval for SENVELGO, the first oral liquid medication for diabetic cats. This groundbreaking treatment simplifies feline diabetes management by allowing a once-daily dosage, either mixed with food or administered directly.
• In May 2023, UBI launched Petrackr, a diabetes monitoring device for pets. It includes a device with single-use test strips for blood sampling and a handheld monitor capable of managing multiple pet profiles. Petrackr effectively tracks and displays pets' blood glucose levels and is available through distribution partnerships in the U.S. and Canada.
• In February 2023, Singapore-based, ALRT, introduced GluCurve Pet CGM, a continuous glucose monitoring device for diabetic cats and dogs, developed in collaboration with Covetrus. This device aims to simplify diabetes management for pets.
• In August 2022, ALR Technologies, a diabetes management firm, announced that it received manufacturing approval from Infinovo Medical Co., Ltd. to place its initial order for GluCurve Pet CGM. This groundbreaking system, expected to be delivered by October 2022, is the first continuous glucose monitoring solution designed specifically for diabetic cats and dogs.
• In March 2022, TeleVet, Inc., a technology provider for veterinary teams, and Boehringer Ingelheim Animal Health USA Inc., a global leader in animal health products, formed a strategic partnership. This collaboration aims to deliver innovative technology and services, enhancing patient care and alleviating the overall workload for veterinary practices.